Pending publication in Pharmacy Times Online is the following, hyperlink to come… In the recent New England Journal of Medicine publication, The Rising Price of Naloxone — Risks to Efforts to Stem Overdose Deaths, R. Gupta and colleagues addressed issues surrounding naloxone access, with a focus on rising costs.1 All points reviewed were spot on, […]

While I can barely muster up the chutzpah to write this blog, I’ve finally reached the end of my rope in tiptoeing around the subject. Call me a TURKEY if you must, but everybody is entitled to pain management. Not everybody is entitled to opioids if they are non-compliant or the risks are shown to […]

Veterans Day is a reflective national holiday to honor those that severed in the US Military. These are the brave men and women that made personal sacrifices to ensure that all citizens, EVEN THOSE WITH CHRONIC PAIN SYNDROMES, are treated fairly and respectfully. Yet, lawmakers and politicians have bastardized that unalienable right in an effort […]

Dr. Fein and I teamed up to whine a bit about wine and alcohol in general and discuss its relationship to opioid abuse or misuse in this country. More importantly this post helps to delineate what the likes and differences are when reaching for an occasional recreational alcoholic beverage versus reaching for an opioid when […]

Despite blistering cold winds, the #RALLYAGAINSTPAIN in Washington DC held at the Ellipse on the National Mall area across from the White House was a success. The real heroes were the patients and their significant others that showed up from all corners of the US Map, from as far west as California all the way to Buffalo NY, Cincinatti […]

…but there is help on the way! While local communities and politicians continue to wave their naloxone access flags at the community in a dogmatic attempt to increase naloxone and save lives from unintentional opioid overdose and opioid-induced respiratory depression (OIRD), the truth is that very little is really happening behind the scenes in comparison […]

Let’s take a look. to see if the LA Times is in fact an oxymoron. Merriam-Webster’s online dictionary defines moron as “a very stupid or foolish person”, but since this country treats corporate entities as people, I’d say LA Times qualifies. Their legal definition is “a person with a mild or moderate intellectual disability —used […]

Before you succumb to the newest opioid epidemic, you may want to visit #OpioidIQ. Allow me to explain. According to Wikipedia, Collective intelligence is shared or group intelligence that emerges from the collaboration, collective efforts, and competition of many individuals and appears in consensus decision making. As I navigate through some of the political rhetoric, I can’t help but ponder the […]

On April 4, 2016 guest bloggers Drs. Jacqueline Pratt Cleary and Joseph Gottwald (a student at the time) posted Buprenorphine, so misunderstood with, as you likely predicted, the old Dr. Pepper parody in tow. That blog focused on the newest buprenorphine dosage form approved by the FDA specifically for the management of chronic pain, Belbuca. This […]

When was the last time you heard a colleague express genuine excitement about learning anything new regarding pain therapeutics? If a game-changer were to emerge, would it matter if no one is still playing the game? For people with pain it’s the bottom of the ninth, two outs, two strikes, bases loaded and the team […]